Across TCGA pan-cancer cohorts, RNU2-62P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU2-62P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU2-62P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU2-62P is over-expressed in tumor.

STAD, BRCA, and LUSC are the cancer types where RNU2-62P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-62P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.245	.012	4	view →
BRCA	Female	All	+0.073	.032	4	view →
LUSC	All	All	+0.083	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU2-62P RNA expression & survival · all RNU2-62P data types